A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
17 03 2020
Historique:
received: 11 10 2019
accepted: 20 12 2019
pubmed: 10 1 2020
medline: 15 9 2020
entrez: 10 1 2020
Statut: epublish

Résumé

Dengue virus (DENV) is a mosquito-borne flavivirus responsible for dengue disease, a major human health concern for which no specific therapies are available. Like other viruses, DENV relies heavily on the host cellular machinery for productive infection. In this study, we performed a genome-wide CRISPR-Cas9 screen using haploid HAP1 cells to identify host genes important for DENV infection. We identified DPM1 and -3, two subunits of the endoplasmic reticulum (ER) resident dolichol-phosphate mannose synthase (DPMS) complex, as host dependency factors for DENV and other related flaviviruses, such as Zika virus (ZIKV). The DPMS complex catalyzes the synthesis of dolichol-phosphate mannose (DPM), which serves as mannosyl donor in pathways leading to N-glycosylation, glycosylphosphatidylinositol (GPI) anchor biosynthesis, and C- or O-mannosylation of proteins in the ER lumen. Mutation in the DXD motif of DPM1, which is essential for its catalytic activity, abolished DPMS-mediated DENV infection. Similarly, genetic ablation of ALG3, a mannosyltransferase that transfers mannose to lipid-linked oligosaccharide (LLO), rendered cells poorly susceptible to DENV. We also established that in cells deficient for DPMS activity, viral RNA amplification is hampered and truncated oligosaccharides are transferred to the viral prM and E glycoproteins, affecting their proper folding. Overall, our study provides new insights into the host-dependent mechanisms of DENV infection and supports current therapeutic approaches using glycosylation inhibitors to treat DENV infection.

Identifiants

pubmed: 31915280
pii: JVI.01751-19
doi: 10.1128/JVI.01751-19
pmc: PMC7081898
pii:
doi:

Substances chimiques

Glycoproteins 0
Glycosylphosphatidylinositols 0
Oligosaccharides 0
RNA, Guide 0
RNA, Viral 0
Mannosyltransferases EC 2.4.1.-
dolichyl-phosphate beta-D-mannosyltransferase EC 2.4.1.83
Mannose PHA4727WTP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Arch Virol. 2005 Apr;150(4):771-86
pubmed: 15592895
Nat Commun. 2017 Feb 20;8:14516
pubmed: 28218252
PLoS Negl Trop Dis. 2012;6(8):e1760
pubmed: 22880140
Genome Biol. 2014;15(12):554
pubmed: 25476604
Antiviral Res. 2016 Jun;130:7-18
pubmed: 26944216
Nat Commun. 2017 Jul 25;8(1):120
pubmed: 28743912
Adv Virus Res. 2014;88:1-109
pubmed: 24373310
Glycobiology. 1996 Jun;6(4):439-44
pubmed: 8842708
J Virol. 2015 Jan 15;89(2):1474-8
pubmed: 25392222
J Clin Invest. 2000 Jan;105(2):233-9
pubmed: 10642602
Nat Microbiol. 2019 Dec;4(12):2369-2382
pubmed: 31384002
J Virol. 2008 Aug;82(16):7846-62
pubmed: 18524814
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9527-9532
pubmed: 31019072
mBio. 2017 Jul 18;8(4):
pubmed: 28720733
Cell Rep. 2017 Dec 26;21(13):3900-3913
pubmed: 29281836
PLoS Pathog. 2010 Oct 21;6(10):e1001157
pubmed: 20975939
Viruses. 2017 Mar 13;9(3):
pubmed: 28335410
Lancet. 2007 Nov 10;370(9599):1644-52
pubmed: 17993365
Methods Mol Biol. 2013;1030:205-19
pubmed: 23821271
J Virol. 2015 Jul;89(14):7235-47
pubmed: 25948743
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Elife. 2018 May 29;7:
pubmed: 29809151
Cell Rep. 2018 May 8;23(6):1779-1793
pubmed: 29742433
Nature. 2016 Jul 7;535(7610):159-63
pubmed: 27383987
Acta Virol. 2013;57(1):27-33
pubmed: 23530821
EMBO J. 1999 Dec 1;18(23):6816-22
pubmed: 10581255
J Biol Chem. 2006 Jan 13;281(2):896-904
pubmed: 16280320
Curr Opin Cell Biol. 2016 Aug;41:57-65
pubmed: 27085638
J Virol. 2005 Nov;79(21):13262-74
pubmed: 16227249
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Viruses. 2017 Apr 30;9(5):
pubmed: 28468299
J Virol. 2014 Aug;88(16):9049-59
pubmed: 24899172
J Virol. 2004 May;78(10):5414-22
pubmed: 15113920
J Virol. 2007 Jul;81(13):7136-48
pubmed: 17459925
Nat Rev Microbiol. 2018 Feb 12;16(3):125-142
pubmed: 29430005
J Biol Chem. 2003 Sep 5;278(36):34119-24
pubmed: 12829701
PLoS Pathog. 2015 Nov 12;11(11):e1005277
pubmed: 26562291
Science. 2018 Jan 26;359(6374):470-473
pubmed: 29242231
FEBS Lett. 2003 Dec 4;555(2):209-16
pubmed: 14644417
J Virol. 2008 Jul;82(13):6631-43
pubmed: 18448542
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7873-8
pubmed: 9223280
J Gen Virol. 1998 Nov;79 ( Pt 11):2631-9
pubmed: 9820138
J Virol. 2015 Oct 14;90(1):92-102
pubmed: 26468529
Virus Genes. 2008 Apr;36(2):323-9
pubmed: 18288598
Science. 2016 Sep 2;353(6303):1033-1036
pubmed: 27701113
Nature. 2019 Oct;574(7777):259-263
pubmed: 31554973
EMBO J. 2001 Jan 15;20(1-2):250-61
pubmed: 11226175
EMBO J. 2000 Jun 1;19(11):2475-82
pubmed: 10835346
Biochim Biophys Acta. 2008 Jun;1780(6):861-8
pubmed: 18387370
Nature. 2016 Jul 7;535(7610):164-8
pubmed: 27383988
Nat Chem Biol. 2014 Nov;10(11):902-10
pubmed: 25325701
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
J Inherit Metab Dis. 2011 Aug;34(4):869-78
pubmed: 21614585
Front Immunol. 2018 Apr 27;9:910
pubmed: 29755477
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):500-5
pubmed: 14699049
J Virol. 2005 Nov;79(21):13725-34
pubmed: 16227292
J Virol. 1989 Dec;63(12):5184-93
pubmed: 2555549
Cell Host Microbe. 2012 Oct 18;12(4):544-57
pubmed: 23084921
J Med Virol. 2008 Jan;80(1):125-33
pubmed: 18041028
Biochim Biophys Acta. 1996 Apr 17;1289(3):336-42
pubmed: 8620017
N Engl J Med. 2015 Sep 24;373(13):1195-206
pubmed: 26214039
Front Microbiol. 2017 Jul 25;8:1415
pubmed: 28791003

Auteurs

Athena Labeau (A)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.

Etienne Simon-Loriere (E)

G5 Evolutionary Genomics of RNA Viruses, Institut Pasteur, Paris, France.

Mohamed-Lamine Hafirassou (ML)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.

Lucie Bonnet-Madin (L)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.

Sarah Tessier (S)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.

Alessia Zamborlini (A)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France.

Thierry Dupré (T)

Laboratoire de Biochimie, Hôpital Bichat-Claude Bernard, Paris, France.

Nathalie Seta (N)

Laboratoire de Biochimie, Hôpital Bichat-Claude Bernard, Paris, France.

Olivier Schwartz (O)

Institut Pasteur, Virus and Immunity Unit, CNRS-UMR3569, Paris, France.

Marie-Laure Chaix (ML)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Laboratoire de Virologie et Département des Maladies Infectieuses, Hôpital Saint-Louis, APHP, Paris, France.

Constance Delaugerre (C)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Laboratoire de Virologie et Département des Maladies Infectieuses, Hôpital Saint-Louis, APHP, Paris, France.

Ali Amara (A)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France ali.amara@inserm.fr laurent.meertens@inserm.fr.

Laurent Meertens (L)

INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France ali.amara@inserm.fr laurent.meertens@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH